Jury Gives Merck Another Vioxx Win

Law360, New York (November 15, 2006, 12:00 AM EST) -- A federal jury said Wednesday that Merck & Co. wasn’t liable for a man’s heart attack, handing the drug company a victory in its fight over withdrawn arthritis drug Vioxx.

Charles Laron Mason said he took the drug for the 10 months leading up to his 2003 heart attack.

Vioxx raked in $2.5 billion in sales a year for Merck until the company pulled it from the shelves in September 2004, following a study that found the drug doubled the risk of heart attack and stroke...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.